These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25225696)

  • 1. FDA likely to further restrict or ban morcellation.
    Brower V
    Lancet Oncol; 2014 Aug; 15(9):e369. PubMed ID: 25225696
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA considers restricting or banning laparoscopic morcellation.
    Brower V
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25313228
    [No Abstract]   [Full Text] [Related]  

  • 3. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
    Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
    JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA warns against power morcellation for hysterectomy and fibroids.
    Wallis L
    Am J Nurs; 2014 Jul; 114(7):16. PubMed ID: 25742335
    [No Abstract]   [Full Text] [Related]  

  • 5. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
    Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
    Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAGL advancing minimally invasive gynecology worldwide: statement to the FDA on power morcellation.
    Brown J
    J Minim Invasive Gynecol; 2014; 21(6):970-1. PubMed ID: 25195157
    [No Abstract]   [Full Text] [Related]  

  • 7. The Morcellation Debate: The History and the Science.
    Adelman MR
    Clin Obstet Gynecol; 2015 Dec; 58(4):710-7. PubMed ID: 26512438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How I do... a minimally invasive laparoscopic total hysterectomy, with extracorporeal manual tissue extraction in 10 steps (with video)].
    Gloaguen S; Belghiti J; Azaïs H; Gonthier C; Nikpayam M; Uzan C; Canlorbe G
    Gynecol Obstet Fertil Senol; 2019 Jun; 47(6):540-544. PubMed ID: 31009799
    [No Abstract]   [Full Text] [Related]  

  • 10. Power morcellation in a specimen bag.
    Cholkeri-Singh A; Miller CE
    J Minim Invasive Gynecol; 2015 Feb; 22(2):160. PubMed ID: 25460317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic morcellation: an acceptable risk or an Achilles heel?
    Garry R
    BJOG; 2015 Mar; 122(4):458-60. PubMed ID: 25236787
    [No Abstract]   [Full Text] [Related]  

  • 12. Dispersive pad injuries associated with hysteroscopic surgery.
    Raders JL
    J Am Assoc Gynecol Laparosc; 1999 Aug; 6(3):363-7. PubMed ID: 10610207
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of morcellation to remove fibroids scrutinized at FDA hearings.
    Hampton T
    JAMA; 2014 Aug; 312(6):588. PubMed ID: 25117116
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation.
    Lum DA; Sokol ER; Berek JS; Schulkin J; Chen L; McElwain CA; Wright JD
    J Minim Invasive Gynecol; 2016; 23(4):548-56. PubMed ID: 26827905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications.
    Siedhoff MT; Doll KM; Clarke-Pearson DL; Rutstein SE
    Am J Obstet Gynecol; 2017 Mar; 216(3):259.e1-259.e6. PubMed ID: 27890646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
    Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
    J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the risks of electric uterine morcellation.
    Kho KA; Nezhat CH
    JAMA; 2014 Mar; 311(9):905-6. PubMed ID: 24504415
    [No Abstract]   [Full Text] [Related]  

  • 18. The need for further surgical intervention following primary hysteroscopic morcellation of submucosal leiomyomas in women with abnormal uterine bleeding.
    Maheux-Lacroix S; Mennen J; Arnold A; Budden A; Nesbitt-Hawes E; Won H; Abbott J
    Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):570-575. PubMed ID: 29355897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.
    Siedhoff MT; Kim KH
    J Surg Oncol; 2015 Dec; 112(7):769-71. PubMed ID: 26768314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Lieng M; Berner E; Busund B
    J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.